Advances in molecular infectious diseases testing in the time of COVID-19
Peaper DR, Kerantzas CA, Durant TJS. Advances in molecular infectious diseases testing in the time of COVID-19. Clinical Biochemistry 2022, 117: 94-101. PMID: 35181291, PMCID: PMC8843810, DOI: 10.1016/j.clinbiochem.2022.02.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Infectious diseasesRespiratory syndrome coronavirus 2Syndrome coronavirus 2COVID-19Public health needsCoronavirus 2Health needsDiagnostic testingCoronavirus diseaseLaboratory responseWidespread testingDiseaseCOVID-19 pandemicLaboratory medicineSample collectionPandemicTestingChallenging eventsDiagnostic manufacturers